文献速递脑血管病外科

脑动静脉畸形患者管理实用性研究中的患者选择

Patient Selection in a Pragmatic Study on the Management of Patients with Brain Arteriovenous Malformations.
PubMed 文献 · World Neurosurg · 2023-02-03

TOBAS是一项包含2项随机对照试验的实用性研究,未纳入随机对照试验的患者进入平行治疗与观察登记组。2014年6月至2021年5月共招募1010例脑动静脉畸形患者,随机对照试验1中139/512例(26%)接受了随机分配。随机对照试验患者与登记组患者在破裂状态、Spetzler-Martin分级和基线改良Rankin评分上存在显著差异(P<0.001)。

要点

  • 随机对照试验1中139/512例(26%)接受随机分配,其中未破裂动静脉畸形127/222例(57%)。
  • 多数患者为小型(<3 cm;71%)、低级别(Spetzler-Martin I-II级;64%)、未破裂(91%)动静脉畸形。
  • 随机对照试验患者与登记组患者在破裂状态、Spetzler-Martin分级和基线改良Rankin评分上差异显著(P<0.001)。

核心结论

  • 随机对照试验纳入的患者与登记组患者存在显著差异。
  • 若多个中心积极参与TOBAS随机对照试验,可获得有意义的结果。

研究设计与样本

  • TOBAS是一项包含2项随机对照试验的全面实用性研究,未纳入随机对照试验的患者进入平行治疗与观察登记组。
  • 2014年6月至2021年5月共招募1010例脑动静脉畸形患者;498例进入观察登记组,373例进入治疗登记组。
  • 随机对照试验1对适合治愈性治疗的患者按1:1随机分配干预与保守管理;随机对照试验2对判断可联合或不联合栓塞治疗的手术或立体定向放射外科患者按1:1随机分配预栓塞或不预栓塞。

主要发现

  • 随机对照试验1中139/512例(26%)接受随机分配,包括未破裂动静脉畸形127/222例(57%)。
  • 随机对照试验1患者与观察或治疗登记组患者在破裂状态、Spetzler-Martin分级和基线改良Rankin评分上存在差异(P<0.001)。
  • 多数患者为小型(<3 cm;71%)、低级别(Spetzler-Martin I-II级;64%)、未破裂(91%)动静脉畸形。
  • 随机对照试验1分配的管理为保守治疗(n=71)或治愈性治疗(n=68),治愈性治疗包括手术(n=39)、栓塞(n=16)或立体定向放射外科(n=13)。
  • 在分配/指定接受手术或立体定向放射外科的309例患者中,179例(58%)考虑预栓塞,其中87/179例(49%)纳入随机对照试验2。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Treatment of Brain Arteriovenous Malformations Study (TOBAS) is an all-inclusive pragmatic study comprising 2 randomized clinical trials (RCTs). Patients excluded from the RCTs are followed in parallel treatment and observation registries, allowing a comparison between RCT and registry patients. METHODS: The first randomized clinical trial (RCT-1) offers 1:1 randomized allocation of intervention versus conservative management for patients with arteriovenous malformation (AVM). The second randomized clinical trial (RCT-2) allocates 1:1 pre-embolization or no pre-embolization to surgery or radiosurgery patients judged treatable with or without embolization. Characteristics of RCT patients are reported and compared to registry patients. RESULTS: From June 2014 to May 2021, 1010 patients with AVM were recruited; 498 patients were observed and 373 were included in the treatment registries. Randomized allocation in RCT-1 was applied to 139 (26%) of the 512 patients (including 127 of 222 [57%] with unruptured AVMs) considered for curative treatment. RCT-1 AVM patients differed (in rupture status, Spetzler-Martin grade and baseline modified Rankin Score) from those in the observation or treatment registries (P < 0.001). Most patients had small (<3 cm; 71%) low-grade (Spetzler-Martin I-II; 64%) unruptured (91%) AVMs. The allocated management was conservative (n = 71) or curative (n = 68), using surgery (n = 39), embolization (n = 16), or stereotactic radiosurgery (n = 13). Pre-embolization was considered for 179/309 (58%) patients allocated/assigned to surgery or stereotactic radiosurgery; 87/179 (49%) were included in RCT-2. RCT-2 patient AVMs differed in size, eloquence and grade from patients of the pre-embolization registry (P < 0.01). Most had small (<3 cm in 82%) low-grade (83%) AVMs in non-eloquent brain (64%). CONCLUSIONS: Patients included in the RCTs differ significantly from registry patients. Meaningful results can be obtained if multiple centers actively participate in the TOBAS RCTs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Raymond J, Benomar A, Gentric JC, et al. Patient Selection in a Pragmatic Study on the Management of Patients with Brain Arteriovenous Malformations. World Neurosurg. 2023. PMID: 36738962. doi:10.1016/j.wneu.2023.01.098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。